| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Sep―17 |
Local and systemic side effects of COVID-19 vaccine in Tunisian cancer patients: A prospective single center study |
Wala Ben Kridis, Olfa Boudawara, Afef Khanfir |
| 2 |
[GO] |
2024―Mrz―08 |
Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients |
Carlos Guzmán Cordero, María Sáez-Torres de Vicente, Álvaro Jiménez Espinosa, Ana Isabel Gago Sánchez |
| 3 |
[GO] |
2022―Jan―11 |
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US |
Lynn Neilson, Monal Kohli, Kiraat D Munshi, Samuel K Peasah, Rochelle Henderson, Vida Passero, Chester B Good |
| 4 |
[GO] |
2021―Dez―14 |
The experience of cancer patients during the COVID-19 pandemic |
Melanie Dalby, Nikant Ailawadi |
| 5 |
[GO] |
2021―Okt―23 |
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners |
Grace Chazan, Jennifer Jupp, Tiene Bauters, Nick Duncan, Kellie Jones Weddle, Hisanaga Nomura, Shaun O’Connor, Alexandre Chan, Nora Alkhudair, Majed Alshamrani, Larry W Buie, Pinkie Chambers, Tan Wen Chieh, David L DeRemer, France Duvivier, Deogratias Katabalo, Thomas McFarlane, Daniel Mckavanagh, Kofi Mensah, Estela Moreno Martinez, Gail Rowan, Manit Sae-teaw, Tamrat Assefa Tadesse, Irene Weru, Marliese Alexander |
| 6 |
[GO] |
2021―Okt―13 |
Potential interactions between antineoplastic agents and medicines used to treat Covid-19 |
Mario Jorge Sobreira da Silva, Claudia Garcia Serpa Osorio-de-Castro, Rafael Duarte Paes, Christopher Lucas Negrete, Elizangela Eugênio, Elaine Lazzaroni Moraes, Annemeri Livinalli |
| 7 |
[GO] |
2021―Sep―30 |
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards |
Deniz C Guven, Imdat Eroglu, Rashad Ismayilov, Ege Ulusoydan, Oktay H Aktepe, Gulcin Telli Dizman, Zafer Arik, Omer Dizdar, Serhat Unal, Gokhan Metan, Neyran Kertmen |
| 8 |
[GO] |
2021―Sep―25 |
Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study |
Zoe Roupa, Maria Noula, Monica Nikitara, Savoula Ghobrial, Evangelos Latzourakis, Giannis Polychronis |
| 9 |
[GO] |
2021―Aug―23 |
Alectinib, COVID-19 and favipiravir |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 10 |
[GO] |
2021―Mai―13 |
Global changes to the chemotherapy service during the covid-19 pandemic |
Man-Chie Chow, Pinkie Chambers, Georgina Singleton, Jignesh Patel, Silvie Cooper, Charlotte Mythen, Elysse Bautista-González, Georgia Chisnall, Nehla Djellouli, Benjamin Thwaites, Ian CK Wong, Cecilia Vindrola-Padros |
| 11 |
[GO] |
2021―Mai―09 |
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? |
Murat Ayhan, Şahin Laçin, Deniz T Özyükseler, Heves Sürmeli, Akif Doğan, Merve Turan, Hatice odabas, Nedim Turan, Mahmut Emre Yıldırım |
| 12 |
[GO] |
2021―Apr―24 |
Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report |
Christopher T Elder, Elizabeth C Davis, Stephanie Jaipal, Charles E Wight |
| 13 |
[GO] |
2021―Feb―11 |
Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic |
Maria Marchese, Angela Heintzman, Mark Pasetka, Flay Charbonneau, Carlo DeAngelis, Christine Peragine |
| 14 |
[GO] |
2021―Jan―28 |
Cancer patient experience of telephone clinics implemented in light of COVID-19 |
Melanie Dalby, Alison Hill, Shereen Nabhani-Gebara |
| 15 |
[GO] |
2021―Jan―20 |
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? |
Emre Yekedüz, Güngör Utkan, Yüksel Ürün |
| 16 |
[GO] |
2021―Jan―18 |
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City |
Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss, Krisoula H Spatz, Andrea C Levoir, Terry K Pak, Phuong H Dao, Michael J Buege, Lauren M Derespiris, Carmen Lau, Jennifer S Orozco, Manpreet Boparai, Lauren A Koranteng, Kate E Reichert, Shirley Q Yan, Nicole P Daukshus, Sherry Mathew, Larry W Buie, Richard F Tizon, Scott Freeswick, Dazhi Liu, Stephen Harnicar |
| 17 |
[GO] |
2020―Nov―02 |
Coping with the residency program during COVID-19: Hematology oncology pharmacy residents’ perspective |
Aeshah A AlAzmi, Fouad AlNajjar, Majed AlShomrani |
| 18 |
[GO] |
2020―Okt―23 |
Response of an oncology unit in the midst of the COVID-19 outbreak |
Michalis Liontos, Efstathios Kastritis, Magdalini Migkou, Konstantinos Koutsoukos, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Theodora Psaltopoulou, Flora Zagouri, Evangelos Terpos, Meletios Athanasios Dimopoulos |
| 19 |
[GO] |
2020―Okt―21 |
Tyrosine kinase inhibitors and COVID-19 |
Başcı Semih, Yiğenoğlu Tuğçe Nur, Dal Mehmet Sinan, Korkmaz Serdal, Turgut Burhan, Altuntaş Fevzi |
| 20 |
[GO] |
2020―Okt―21 |
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors |
Banu Cakir |
| 21 |
[GO] |
2020―Okt―08 |
Optimizing the role of ambulatory chemotherapy in response to the Covid-19 pandemic |
Racha Sabbagh Dit Hawasli, Shereen Nabhani-Gebara |
| 22 |
[GO] |
2020―Sep―29 |
A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia |
Feriel Letaief, Imen Gharbi, Adel Hamdi, Yosra Yahyaoui, Mona Ayadi, Imen Blousa, Amel Mezlini |
| 23 |
[GO] |
2020―Sep―25 |
Clinical strategies for optimizing infusion center care through a pandemic |
Kirollos S Hanna, Eve M Segal, Ashley Barlow, Brooke Barlow |
| 24 |
[GO] |
2020―Aug―28 |
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors |
Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroğlu, Abdülkadir Baştürk, Tuba Hacıbekiroğlu, Mehmet Hilmi Doğu, İlhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Murat Çağlayan, Mustafa Okan Ayvalı, Osman Çelik, Mustafa Mahir Ülgü, Şuayip Birinci |
| 25 |
[GO] |
2020―Aug―14 |
Switch in use of midazolam for cancer patients during the COVID-19 pandemic |
Guillaume Marliot, Nicolas Penel, Vincent Gamblin |
| 26 |
[GO] |
2020―Aug―14 |
Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic |
Yosra Yahyaoui, Zahra Ghodhbani, Adel Hamdi, Feryel Letaief, Yosr Zenzri, Azza Ben Said, Imen Blouza, Amel Mezlini |
| 27 |
[GO] |
2020―Jul―06 |
Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? |
Elif Aras-Atik, Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu |
| 28 |
[GO] |
2020―Jun―25 |
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations |
Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Abdulaziz Ben Obaid, Amr Khardaly, Eshtyag Bajnaid, Hadeel Samarkandi, Aeshah AlAzmi, Salman Alabdali, Mohammed AlNahedh |
| 29 |
[GO] |
2020―Jun―07 |
Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider? |
Mark A Marinella |
| 30 |
[GO] |
2020―Mai―29 |
Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan |
Satoru Mitsuboshi, Masaki Yoshino, Hiroki Hosokawa, Hirokazu Isobe, Kenichi Kobayashi |
| 31 |
[GO] |
2020―Mai―19 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab |
Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, Güngör Utkan, Yüksel Ürün |
| 32 |
[GO] |
2020―Mai―15 |
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety |
Marliese Alexander, Jennifer Jupp, Grace Chazan, Shaun O’Connor, Alexandre Chan |
|
